#piramal-pharma
FII exodus! Top 10 stocks which saw sharpest decline in foreign capital in Q1. See full list
Foreign institutional investors have markedly scaled back their holdings in various Indian firms. Notably, Piramal Pharma faced the steepest decline, with FII ownership plummeting by 17.7 percentage points. RBL Bank also saw a significant drop of 11.4 percent…
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
MUMBAI, India, July 7, 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platf…
Piramal Pharma SolutionsPiramal Pharma Solutions、Botanixとの提携を発表し、、原薬開発をサポート
【画像：https://kyodonewsprwire.jp/img/202605189239-O2-o5ju8NBu】 ・Piramal Pharma Solutionsは、Botanix Pharmaceuticals Limitedの子会社であるBotanix SB Inc.と、Sofdra®の開発と商業供給をサポートする契約を締結しました。・Sofdraは、原発性腋窩多汗症の治療薬として初めてFDAに承認された唯一の新規...
Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra®. Sofdra is the first and only FDA-approved new chemical entity (NCE) for …